Brief: Mabion Signs New Deal With Brazil's IBMP For Drug Manufacturing Technology Transfer
18/08/2025 15:25
Aug 18 (Reuters) - Mabion SA MABP.WA: SIGNS ANOTHER DEAL WITH IBMP UNDER SOW#2 FRAMEWORK DEAL NET REMUNERATION FOR PROJECT MANAGEMENT IS APPROX. 1.6 MILLION PLN SOW#2 INVOLVES TECHNOLOGY TRANSFER FOR DRUG MANUFACTURING Source text: ID:nEM2jBBzza Further company coverage: MABP.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Partner Oddifact Says FDA Consultations Allow MabionCD20 To Be Used As First-Line Therapy For ITP
Brief: Mabion Holds Pre-IND Type B Meeting With FDA On MabionCD20 Development For ITP
Brief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Q2 Net Loss At 15 Mln Zlotys
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects